FindTrial
Sign In

A prospective study for comparing postoperative disease-free survival and quality of life after modified radical mastectomy versus expanded Mckissock surgery for extensive intraductal carcinoma of the breast

A prospective study for comparing postoperative disease-free survival and quality of life after modified radical mastectomy versus expanded Mckissock surgery for extensive intraductal carcinoma of the breast

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900025097
Enrollment
Unknown
Registered
2019-08-10
Start date
2019-10-01
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast neoplasms

Interventions

Experimental group:Expanded Mckissock surgery
Control group:Modified radical mastectomy

Sponsors

Shengjing Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients with extensive intraductal carcinoma confirmed by hollow needle biopsy; 2. the lesion not involving the nipple as confirmed by enhanced MR imaging of the breast; 3. Bra cup size B or higher; 4. postmenopausal patients; 5. provision of written informed consent.

Exclusion criteria

Exclusion criteria: 1. The cutting edge of nipple-areola complex tested positive for extensive intraductal carcinoma twice; 2. preoperative nipple hemorrhage; 3. bilateral breast cancer; 4. inflammatory breast cancer; 5. distant metastasis; 6. other cancers or those who receive chest radiotherapy.

Design outcomes

Primary

MeasureTime frame
Disease-free survival;—

Secondary

MeasureTime frame
Quality of life;Breast symmetry;Medical costs;—

Countries

China

Contacts

Public ContactJianyi Li

Shengjing Hospital of China Medical University

sjbreast@yeah.net+86 18940257177

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026